UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

Chest, 2013, Vol.143 (1), p.179-184

2013

Volltextzugriff (PDF)

Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice

The American journal of medicine, 2017-02, Vol.130 (2), p.135-145

2017

Volltextzugriff (PDF)

Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational studies

The Journal of thoracic and cardiovascular surgery, 2012-03, Vol.143 (3), p.665-675.e4

2012

Volltextzugriff (PDF)

Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

The American journal of cardiology, 2013-08, Vol.112 (4), p.493-498

2013

Volltextzugriff (PDF)

Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry

The American journal of medicine, 2015-05, Vol.128 (5), p.509-518.e2

2015

Volltextzugriff (PDF)

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

Journal of the American College of Cardiology, 2013-09, Vol.62 (11), p.981-989

2013

Volltextzugriff (PDF)

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

Journal of the American College of Cardiology, 2012-08, Vol.60 (8), p.738-746

2012

Volltextzugriff (PDF)

Inflammation in Atrial Fibrillation

Journal of the American College of Cardiology, 2012-12, Vol.60 (22), p.2263-2270

2012

Volltextzugriff (PDF)

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

The American journal of medicine, 2010-07, Vol.123 (7), p.638-645.e4

2010

Volltextzugriff (PDF)

International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)

The American heart journal, 2012, Vol.163 (1), p.13-19.e1

2012

Volltextzugriff (PDF)

Volume Status and Diuretic Therapy in Systolic Heart Failure and the Detection of Early Abnormalities in Renal and Tubular Function

Journal of the American College of Cardiology, 2011-05, Vol.57 (22), p.2233-2241

2011

Volltextzugriff (PDF)

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)

The American heart journal, 2015-04, Vol.169 (4), p.472-478.e5

2015

Volltextzugriff (PDF)

Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation

The American heart journal, 2014-03, Vol.167 (3), p.329-334

2014

Volltextzugriff (PDF)

Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation Patients

Journal of the American College of Cardiology, 2011-06, Vol.57 (25), p.2496-2504

2011

Volltextzugriff (PDF)

Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (From the Fushimi AF Registry)

The American journal of cardiology, 2017-04, Vol.119 (8), p.1229-1237

2017

Volltextzugriff (PDF)

Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation

The American journal of medicine, 2014-07, Vol.127 (7), p.650-656.e5

2014

Volltextzugriff (PDF)

Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease

Journal of the American College of Cardiology, 2016-09, Vol.68 (13), p.1452-1464

2016

Volltextzugriff (PDF)

Body Mass Index and Adverse Events in Patients with Incident Atrial Fibrillation

The American journal of medicine, 2013-07, Vol.126 (7), p.640.e9-640.e17

2013

Volltextzugriff (PDF)

Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study

The American journal of medicine, 2012-08, Vol.125 (8), p.826.e13-826.e23

2012

Volltextzugriff (PDF)

Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (From the AF-CVS Score)

The American journal of cardiology, 2017-03, Vol.119 (5), p.749-752

2017

Volltextzugriff (PDF)

Renal Impairment in a “Real-Life” Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)

The American journal of cardiology, 2013-04, Vol.111 (8), p.1159-1164

2013

Volltextzugriff (PDF)

Autonomic function and rheumatoid arthritis—A systematic review

Seminars in arthritis and rheumatism, 2014-12, Vol.44 (3), p.283-304

2014

Volltextzugriff (PDF)

Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study

Mayo Clinic proceedings, 2016-05, Vol.91 (5), p.567-574

2016

Volltextzugriff (PDF)

Current Understanding of Atherogenesis

The American journal of medicine, 2017-03, Vol.130 (3), p.268-282

2017

Volltextzugriff (PDF)

Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

The American journal of medicine, 2014-10, Vol.127 (10), p.972-978

2014

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(142)

Publikationsform

Artikel
(147)

Sprache

Englisch
(147)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Cardiovascular
(83)
Life Sciences & Biomedicine
(81)
Science & Technology
(81)
Humans
(78)
Internal Medicine
(65)
Male
(51)
Cardiovascular System & Cardiology
(50)
Female
(50)
Cardiac & Cardiovascular Systems
(46)
Atrial Fibrillation
(45)
Aged
(42)
Stroke
(42)
Atrial Fibrillation - Complications
(37)
Cardiac Arrhythmia
(36)
Middle Aged
(30)
Pulmonary/respiratory
(30)
Anticoagulants
(28)
Anticoagulants - Therapeutic Use
(28)
Atrial Fibrillation - Drug Therapy
(26)
Risk Factors
(26)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice

Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational studies

Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

Inflammation in Atrial Fibrillation

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)

Volume Status and Diuretic Therapy in Systolic Heart Failure and the Detection of Early Abnormalities in Renal and Tubular Function

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)

Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation

Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation Patients

Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (From the Fushimi AF Registry)

Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation

Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease

Body Mass Index and Adverse Events in Patients with Incident Atrial Fibrillation

Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study

Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (From the AF-CVS Score)

Renal Impairment in a “Real-Life” Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)

Autonomic function and rheumatoid arthritis—A systematic review

Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study

Current Understanding of Atherogenesis

Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

Suchergebnisse filtern